Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.8B | 6.6B | 5.7B | 5.0B |
Cost of revenue | 6.7B | 4.6B | 4.1B | 3.7B |
Gross profit | 3.2B | 2.0B | 1.6B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.0B | 519.8M | 427.5M | 371.9M |
Operating income | 1.5B | 831.8M | 735.3M | 585.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 294.6M | 269.8M | 221.4M | 227.2M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 808.5M | 849.4M | 641.2M |
Tax provision | 257.3M | 143.9M | 247.4M | 133.4M |
Net income | 1.2B | 664.6M | 602.1M | 507.8M |
Basic EPS | — | 10.4 | 9.4 | 7.9 |
Diluted EPS | — | 10.3 | 9.3 | 7.8 |
Basic average shares | — | 64.0M | 64.2M | 64.0M |
Diluted average shares | — | 64.7M | 64.8M | 64.8M |
EBITDA | 1.9B | 1.2B | 1.2B | 952.1M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |